Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Shinichi Sakuramoto is a pioneering surgeon advancing the frontier of minimally invasive cancer surgery through the adoption and refinement of next-generation robotic platforms. His research focuses on the clinical application of the Senhance Digital Laparoscopy System for colorectal and gastric cancers, with a particular emphasis on reducing surgical invasiveness without compromising oncologic outcomes. Dr. Sakuramoto’s major contributions include performing the first Senhance-assisted ileocecal resection and sigmoid colectomy in Japan, as well as pioneering single-incision plus one- or two-port robotic techniques for colon cancer—demonstrating that complex resections can be safely achieved with fewer ports. His work also extends to gastric surgery, where he reported the first Senhance-assisted local gastrectomy for gastrointestinal stromal tumors and showed that robot-assisted distal gastrectomy offers superior postoperative inflammatory profiles in obese patients compared to conventional laparoscopy. With papers accumulating up to 28 citations and growing, his studies have collectively shaped early evidence for the Senhance system’s safety, feasibility, and potential advantages. Dr. Sakuramoto’s innovative case reports and comparative analyses are instrumental in guiding the next generation of robotic colorectal and gastric surgery.